American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (687)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (589)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2704)
  2. Clinical Cancer Research (1445)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Plasma protein biomarkers in advanced or metastatic colorectal cancer patients receiving chemotherapy with bevacizumab or cetuximab: Results from CALGB 80405 (Alliance)
    Journal Article

    Nixon, A. B.; Sibley, A. B.; Liu, Y.; Hatch, A. J.; Jiang, C.; Mulkey, F.; Starr, M. D.; Brady, J. C.; Niedzwiecki, D.; Venook, A. P.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Replication of overall survival, progression-free survival, and overall response in chemotherapy arms of non-small cell lung cancer trials using real-world data
    Journal Article

    Ton, T. G. N.; Pal, N.; Trinh, H.; Mahrus, S.; Bretscher, M. T.; Machado, R. J. M.; Sadetsky, N.; Chaudhary, N.; Lu, M. W.; Riely, G. J.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A randomized phase II study of MEDI0680 in combination with durvalumab versus nivolumab monotherapy in patients with advanced or metastatic clear-cell renal cell carcinoma
    Journal Article

    Voss, M. H.; Azad, A. A.; Hansen, A. R.; Gray, J. E.; Welsh, S. J.; Song, X.; Kuziora, M.; Meinecke, L.; Blando, J.; Achour, I.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Ultrasmall nanoparticle delivery of doxorubicin improves therapeutic index for high-grade glioma
    Journal Article

    Aragon-Sanabria, V.; Aditya, A.; Zhang, L.; Chen, F.; Yoo, B.; Cao, T.; Madajewski, B.; Lee, R.; Turker, M. Z.; Ma, K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Circulating tumor DNA is associated with response and survival in patients with advanced leiomyosarcoma
    Journal Article

    Madanat-Harjuoja, L. M.; Klega, K.; Lu, Y.; Shulman, D. S.; Thorner, A. R.; Nag, A.; Tap, W. D.; Reinke, D. K.; Diller, L.; Ballman, K. V.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • The role of the TP53 pathway in predicting response to neoadjuvant therapy in esophageal adenocarcinoma
    Journal Article

    Sihag, S.; Nussenzweig, S. C.; Walch, H. S.; Hsu, M.; Tan, K. S.; De La Torre, S.; Janjigian, Y. Y.; Maron, S. B.; Ku, G. Y.; Tang, L. H.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • An ascendant challenge: Central nervous system metastases in ALK+ lung cancers
    Editorial

    Murciano-Goroff, Y. R.; Harada, G.; Drilon, A.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Circulating immune cell and outcome analysis from the phase II study of PD-L1 blockade with durvalumab for newly diagnosed and recurrent glioblastoma
    Journal Article

    Nayak, L.; Standifer, N.; Dietrich, J.; Clarke, J. L.; Dunn, G. P.; Lim, M.; Cloughesy, T.; Gan, H. K.; Flagg, E.; George, E.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Identification and management of pathogenic variants in BRCA1, BRCA2, and PALB2 in a tumor-only genomic testing program
    Journal Article

    Bychkovsky, B. L.; Li, T.; Sotelo, J.; Tayob, N.; Mercado, J.; Gomy, I.; Chittenden, A.; Kane, S.; Stokes, S.; Hughes, M. E.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A phase I study investigating AZD8186, a potent and selective inhibitor of PI3Kβ/δ, in patients with advanced solid tumors
    Journal Article

    Choudhury, A. D.; Higano, C. S.; de Bono, J. S.; Cook, N.; Rathkopf, D. E.; Wisinski, K. B.; Martin-Liberal, J.; Linch, M.; Heath, E. I.; Baird, R. D.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: